Author

S. A. Wani

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 4 Organism:human· 4 Approach:statistical model· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Assay:ChIP-seq· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2

Frequent Co-Authors

M. D. Long· 4 shared M. J. Campbell· 4 shared J. S. Gray· 3 shared M. Siddappa· 3 shared S. Hussain· 3 shared C. Yates· 2 shared D. Nayak· 2 shared H. Tang· 2 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

M. D. Long

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Epigenetic disruption of the RARγ complex impairs its function to bookmark AR enhancer interactions required for enzalutamide sensitivity in prostate cancer

S. A. Wani, S. Hussain, J. S. Gray, D. Nayak, H. Tang, L. M. Perez, M. D. Long, M. Siddappa, C. McCabe, L. Campbell, M. R. Freeman, M. J. Campbell

This study identifies RARγ's role in bookmarking AR enhancer interactions in prostate cancer, showing its impact on enzalutamide sensitivity and lineage plasticity.

bioRxiv · Dec 15, 2023 · PreprintCancer Biology

The MYC axis in advanced prostate cancer is impacted through concurrent targeting of ERβ and AR using a novel ERβ-selective ligand alongside Enzalutamide

J. S. Gray, S. A. Wani, S. Hussain, P. Huang, D. Nayak, M. D. Long, C. Yates, S. K. Clinton, C. E. Bennett, C. C. Coss, M. J. Campbell

This study shows that combining a novel ERβ ligand with Enzalutamide reduces MYC signaling and growth in advanced prostate cancer.

bioRxiv · Nov 15, 2023 · PreprintCancer Biology

Vitamin D receptor cistrome-transcriptome analyses establishes quantitatively distinct receptor genomic interactions in African American prostate cancer regulated by BAZ1A

M. Siddappa, S. Hussain, S. A. Wani, H. Tang, H. Jafari, J. S. Gray, M. D. Long, I. Elhussin, B. Karanam, H. Wang, R. Morgan, G. Hardiman, I. B. Adelani, S. Rotimi, A. R. Murphy, , M. J. Campbell

The paper analyzes VDR genomic interactions in African American prostate cancer cells and identifies BAZ1A as a regulator of VDR-dependent transcriptional responses.

bioRxiv · Jan 31, 2022 · PreprintCancer Biology

Genome-wide analyses of transcription factors and co-regulators across seven cohorts identified reduced PPARGC1A expression as a driver of prostate cancer progression

M. Siddappa, S. A. Wani, M. D. Long, D. A. Leach, E. A. Mathe, C. L. Bevan, M. J. Campbell

bioRxiv · May 12, 2020 · PreprintCancer Biology